DENVER INVESTMENT ADVISORS LLC - ALBANY MOLECULAR RESH INC ownership

ALBANY MOLECULAR RESH INC's ticker is AMRI and the CUSIP is 012423109. A total of 135 filers reported holding ALBANY MOLECULAR RESH INC in Q4 2016. The put-call ratio across all filers is 0.14 and the average weighting 0.2%.

Quarter-by-quarter ownership
DENVER INVESTMENT ADVISORS LLC ownership history of ALBANY MOLECULAR RESH INC
ValueSharesWeighting
Q1 2017$430,000
-28.3%
30,636
-4.2%
0.02%
-24.0%
Q4 2016$600,000
+97.4%
31,986
+132.5%
0.02%
+150.0%
Q3 2014$304,000
+166.7%
13,756
+22.0%
0.01%
+233.3%
Q4 2013$114,000
-21.4%
11,2790.0%0.00%0.0%
Q3 2013$145,00011,2790.00%
Other shareholders
ALBANY MOLECULAR RESH INC shareholders Q4 2016
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 567,400$11,473,00012.05%
Permian Investment Partners, LP 1,875,650$37,926,0007.67%
OBERMEYER WOOD INVESTMENT COUNSEL, LLLP 1,490,174$30,131,0002.57%
AMERICAN CAPITAL MANAGEMENT INC 993,280$20,084,0001.91%
Netols Asset Management, Inc. 387,471$7,835,0001.54%
RICE HALL JAMES & ASSOCIATES, LLC 1,158,759$23,430,0001.35%
Evercore Wealth Management, LLC 1,233,880$24,948,0001.13%
Visium Asset Management, LP 3,200,000$64,704,0000.92%
Granite Investment Partners, LLC 303,787$6,143,0000.57%
FRANKLIN STREET ADVISORS INC /NC 144,125$2,914,0000.52%
View complete list of ALBANY MOLECULAR RESH INC shareholders